Caribou Biosciences Inc Financial Flexibility Index
Caribou Biosciences Inc financial flexibility index. Caribou Biosciences Inc (CRBU) has a Financial Flexibility Index of -0.51x as of June 2026. Free cash flow of $-22.79 Million (operating CF $-22.79 Million minus capex $1.00K) represents -1% of total liabilities ($44.67 Million). See cash generation quality of Caribou Biosciences Inc to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Caribou Biosciences Inc (2019–2025)
Financial flexibility index of Caribou Biosciences Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Caribou Biosciences Inc across 7 annual periods. Explore Caribou Biosciences Inc (CRBU) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Caribou Biosciences Inc Financial Flexibility Index by Year (2019–2025)
Caribou Biosciences Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Caribou Biosciences Inc. For the full cash flow conversion analysis, see CRBU cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.06x | $-109.63 Million | $-110.99 Million | $53.19 Million | ▲ +5.5% |
| 2024 | -2.18x | $-131.69 Million | $-138.20 Million | $60.36 Million | ▼ -70.4% |
| 2023 | -1.28x | $-81.68 Million | $-93.29 Million | $63.81 Million | ▼ -11.2% |
| 2022 | -1.15x | $-83.91 Million | $-90.97 Million | $72.89 Million | ▼ -113.5% |
| 2021 | -0.54x | $-29.40 Million | $-32.52 Million | $54.53 Million | ▼ -0.5% |
| 2020 | -0.54x | $-31.90 Million | $-33.22 Million | $59.48 Million | ▲ +6.1% |
| 2019 | -0.57x | $-31.12 Million | $-32.01 Million | $54.47 Million | — |